| 臺大學術典藏 |
2020-12-02T02:33:30Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Chang Y.-L.; Yang C.-Y.; Lin M.-W.; Wu C.-T.; Pan-Chyr Yang; Chang Y.-L.; Yang C.-Y.; Lin M.-W.; Wu C.-T.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:30Z |
miR-146a and miR-370 coordinate enterovirus 71-induced cell apoptosis through targeting SOS1 and GADD45β
|
Chang Y.-L.; Ho B.-C.; Sher S.; Yu S.-L.; Pan-Chyr Yang; Chang Y.-L.; Ho B.-C.; Sher S.; Yu S.-L.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:29Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Pan-Chyr Yang; Yang T.-Y.; Chang G.-C.; Tseng C.-H.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:29Z |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; Hsu Y.-C.; Pan-Chyr Yang; Shih J.-Y.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; Hsu Y.-C.; PAN-CHYR YANG; Shih J.-Y. |
| 臺大學術典藏 |
2020-12-02T02:33:29Z |
Mining missing membrane proteins by high-ph reverse-phase stagetip fractionation and multiple reaction monitoring mass spectrometry
|
Kitata R.B.; Dimayacyac-Esleta B.R.T.; Choong W.-K.; Tsai C.-F.; Lin T.-D.; Tsou C.-C.; Weng S.-H.; Chen Y.-J.; Pan-Chyr Yang; Arco S.D.; Nesvizhskii A.I.; Sung T.-Y.; Chen Y.-J.; Kitata R.B.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:29Z |
R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability
|
Chen H.-Y.; Yu S.-L.; Ho B.-C.; Su K.-Y.; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; Yu C.-J.; Chen K.-Y.; Tsai Y.-H.; Su W.-C.; Chen H.-W.; Chen J.J.W.; Chen C.-J.; Chang G.-C.; Pan-Chyr Yang; Li K.-C.; Chen H.-Y.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:28Z |
Novel Noxipoint Therapy versus Conventional Physical Therapy for Chronic Neck and Shoulder Pain: Multicentre Randomised Controlled Trials
|
Koo C.C.;Lin R.S.;Wang T.-G.;Tsauo J.-Y.;Pan-Chyr Yang;Yen C.-T.;Biswal S.; Koo C.C.; Lin R.S.; Wang T.-G.; Tsauo J.-Y.; PAN-CHYR YANG; Yen C.-T.; Biswal S. |
| 臺大學術典藏 |
2020-12-02T02:33:28Z |
Fluorescence-guided probes of aptamer-targeted gold nanoparticles with computed tomography imaging accesses for in vivo tumor resection
|
Li C.-H.;Kuo T.-R.;Su H.-J.;Lai W.-Y.;Pan-Chyr Yang;Chen J.-S.;Wang D.-Y.;Wu Y.-C.;Chen C.-C.; Li C.-H.; Kuo T.-R.; Su H.-J.; Lai W.-Y.; PAN-CHYR YANG; Chen J.-S.; Wang D.-Y.; Wu Y.-C.; Chen C.-C. |
| 臺大學術典藏 |
2020-12-02T02:33:28Z |
Estrogen receptor gene polymorphisms and lung adenocarcinoma risk in never-smoking women
|
Chen K.-Y.; Hsiao C.-F.; Chang G.-C.; Tsai Y.-H.; Su W.-C.; Chen Y.-M.; Huang M.-S.; Tsai F.-Y.; Jiang S.-S.; Chang I.-S.; Chen C.-Y.; Hsiung C.A.; Chen C.-J.; Pan-Chyr Yang; Chen K.-Y.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:28Z |
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression
|
Yuan A.; Hsiao Y.-J.; Chen H.-Y.; Chen H.-W.; Ho C.-C.; Chen Y.-Y.; Liu Y.-C.; Hong T.-H.; Yu S.-L.; Chen J.J.W.; Pan-Chyr Yang; Yuan A.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:27Z |
MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma
|
Wang L.-K.; Pan S.-H.; Chang Y.-L.; Hung P.-F.; Kao S.-H.; Wang W.-L.; Lin C.-W.; Yang S.-C.; Liang C.-H.; Wu C.-T.; Hsiao T.-H.; Hong T.-M.; Pan-Chyr Yang; Wang L.-K.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:27Z |
EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma
|
Chen H.-Y.; Liu C.-H.; Chang Y.-H.; Yu S.-L.; Ho B.C.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Chang C.-S.; Li Y.-C.; Li K.-C.; Chang G.-C.; Pan-Chyr Yang; Chen H.-Y.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:27Z |
Rapid High-pH Reverse Phase StageTip for Sensitive Small-Scale Membrane Proteomic Profiling
|
Dimayacyac-Esleta B.R.T.; Tsai C.-F.; Kitata R.B.; Lin P.-Y.; Choong W.-K.; Lin T.-D.; Wang Y.-T.; Weng S.-H.; Pan-Chyr Yang; Arco S.D.; Sung T.-Y.; Chen Y.-J.; Dimayacyac-Esleta B.R.T.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:27Z |
SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma
|
Hsiao Y.-J.; Su K.-Y.; Hsu Y.-C.; Chang G.-C.; Chen J.-S.; Chen H.-Y.; Hong Q.-S.; Hsu S.-C.; Kang P.-H.; Hsu C.-Y.; Ho B.-C.; Yang T.-H.; Wang C.-Y.; Jou Y.-S.; Pan-Chyr Yang; Yu S.-L.; Hsiao Y.-J.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:26Z |
A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects
|
Lai W.-Y.; Huang B.-T.; Wang J.-W.; Lin P.-Y.; Pan-Chyr Yang; Lai W.-Y.; Huang B.-T.; Wang J.-W.; Lin P.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:26Z |
Uncovering synthetic lethal interactions for therapeutic targets and predictive markers in lung adenocarcinoma
|
Chang J.-G.; Chen C.-C.; Wu Y.-Y.; Che T.-F.; Huang Y.-S.; Yeh K.-T.; Shieh G.S.; Pan-Chyr Yang; Chang J.-G.; Chen C.-C.; Wu Y.-Y.; Che T.-F.; Huang Y.-S.; Yeh K.-T.; Shieh G.S.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:26Z |
Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations
|
Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Pan-Chyr Yang; Shih J.-Y.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; PAN-CHYR YANG; Shih J.-Y. |
| 臺大學術典藏 |
2020-12-02T02:33:25Z |
MicroRNA and pathogenesis of enterovirus infection
|
Ho B.-C.;Pan-Chyr Yang;Yu S.-L.; Ho B.-C.; PAN-CHYR YANG; Yu S.-L. |
| 臺大學術典藏 |
2020-12-02T02:33:25Z |
Factors in association between Parkinson disease and risk of cancer in Taiwan - Reply
|
Lin P.-Y.; Lin C.-H.; Pan-Chyr Yang; Lin P.-Y.; Lin C.-H.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:25Z |
Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition
|
Lin C.-W.;Lin P.-Y.;Pan-Chyr Yang; Lin C.-W.; Lin P.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:24Z |
Fanconi anemia genes in lung adenocarcinoma - A pathway-wide study on cancer susceptibility
|
Yang S.-Y.; Hsiung C.-N.; Li Y.-J.; Chang G.-C.; Tsai Y.-H.; Chen K.-Y.; Huang M.-S.; Su W.-C.; Chen Y.-M.; Hsiung C.A.; Pan-Chyr Yang; Chen C.-J.; Wu P.-E.; Yu J.-C.; Shen C.-Y.; Hsu H.-M.; Yang S.-Y.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:24Z |
Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women
|
Wang Z.; Seow W.J.; Shiraishi K.; Hsiung C.A.; Matsuo K.; Liu J.; Chen K.; Yamji T.; Yang Y.; Chang I.-S.; Wu C.; Hong Y.-C.; Burdett L.; Wyatt K.; Chung C.C.; Li S.A.; Yeager M.; Hutchinson A.; Hu W.; Caporaso N.; Landi M.T.; Chatterjee N.; Song M.; Fraumeni J.F.; Jr.; Kohno T.; Yokota J.; Kunitoh H.; Ashikawa K.; Momozawa Y.; Daigo Y.; Mitsudomi T.; Yatabe Y.; Hida T.; Hu Z.; Dai J.; Ma H.; Jin G.; Song B.; Wang Z.; Cheng S.; Yin Z.; Li X.; Ren Y.; Guan P.; Chang J.; Tan W.; Chen C.-J.; Chang G.-C.; Tsai Y.-H.; Su W.-C.; Chen K.-Y.; Huang M.-S.; Chen Y.-M.; Zheng H.; Li H.; Cui P.; Guo H.; Xu P.; Liu L.; Iwasaki M.; Shimazu T.; Tsugane S.; Zhu J.; Jiang G.; Fei K.; Park J.Y.; Kim Y.H.; Sung J.S.; Park K.H.; Kim Y.T.; Jung Y.J.; Kang C.H.; Park I.K.; Kim H.N.; Jeon H.-S.; Choi J.E.; Choi Y.Y.; Kim J.H.; Oh I.-J.; Kim Y.-C.; Sung S.W.; Kim J.S.; Yoon H.-I.; Kweon S.-S.; Shin M.-H.; Seow A.; Chen Y.; Lim W.-Y.; Liu J.; Wong M.P.; Lee V.H.F.; Bassig B.A.; Tucker M.; Berndt S.I.; Chow W.-H.; Ji B.-T.; Wang J.; Xu J.; Sihoe A.D.L.; Ho J.C.M.; Chan J.K.C.; Wang J.-C.; Lu D.; Zhao X.; Zhao Z.; Wu J.; Chen H.; Jin L.; Wei F.; Wu G.; An S.-J.; Zhang X.-C.; Su J.; Wu Y.-L.; Gao Y.-T.; Xiang Y.-B.; He X.; Li J.; Zheng W.; Shu X.-O.; Cai Q.; Klein R.; Pao W.; Lawrence C.; Hosgood H.D.; Iii, Hsiao C.-F.; Chien L.-H.; Chen Y.-H.; Chen C.-H.; Wang W.-C.; Chen C.-Y.; Wang C.-L.; Yu C.-J.; Chen H.-L.; Su Y.-C.; Tsai F.-Y.; Chen Y.-S.; Li Y.-J.; Yang T.-Y.; Lin C.-C.; Pan-Chyr Yang; Wu T.; Lin D.; Zhou B.; Yu J.; Shen H.; Kubo M.; Chanock S.J.; Rothman N.; Lan Q.; Wang Z.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:23Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu K.-L.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Pan-Chyr Yang; Chen L.-Y.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:23Z |
Acquisition of tumorigenic potential and enhancement of angiogenesis in pulmonary stem/progenitor cells through Oct-4 hyperexpression
|
Gu S.-Y.; Ho C.-C.; Huang Y.-K.; Chen H.-W.; Wang Y.-C.; Kuo C.-Y.; Teng S.-C.; Fu W.-M.; Pan-Chyr Yang; Wu C.-W.; Peng F.-C.; Ling T.-Y.; Gu S.-Y.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:23Z |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; Pan-Chyr Yang; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.; Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; PAN-CHYR YANG; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y. |
| 臺大學術典藏 |
2020-12-02T02:33:23Z |
Heterogeneous nuclear ribonucleoproteins A1 and A2 modulate expression of Tid1 isoforms and EGFR signaling in non-small cell lung cancer
|
Chen C.-Y.; Jan C.-I.; Pi W.-C.; Wang W.-L.; Pan-Chyr Yang; Wang T.-H.; Karni R.; Wang T.-C.V.; Chen C.-Y.; Jan C.-I.; Pi W.-C.; Wang W.-L.; PAN-CHYR YANG; Wang T.-H.; Karni R.; Wang T.-C.V. |
| 臺大學術典藏 |
2020-12-02T02:33:22Z |
High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma
|
Chang Y.-L.; Yang C.-Y.; Lin M.-W.; Wu C.-T.; Pan-Chyr Yang; Chang Y.-L.; Yang C.-Y.; Lin M.-W.; Wu C.-T.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:22Z |
78P LCRMP-1 associated aptamers inhibit tumor metastasis
|
Hung P.-F.; Chang Y.-C.; Hong T.-M.; Pan-Chyr Yang; Pan S.-H.; Hung P.-F.; Chang Y.-C.; Hong T.-M.; PAN-CHYR YANG; Pan S.-H. |
| 臺大學術典藏 |
2020-12-02T02:33:22Z |
Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage i pulmonary squamous cell carcinoma
|
Yang C.-Y.; Lin M.-W.; Chang Y.-L.; Wu C.-T.; Pan-Chyr Yang; Yang C.-Y.; Lin M.-W.; Chang Y.-L.; Wu C.-T.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:22Z |
Small molecule T315 promotes casitas b-lineage lymphoma dependent degradation of epidermal growth factor receptor via Y1045 autophosphorylation
|
Huang K.-Y.; Kao S.-H.; Wang W.-L.; Chen C.-Y.; Hsiao T.-H.; Salunke S.B.; Chen J.J.W.; Su K.-Y.; Yang S.-C.; Hong T.-M.; Chen C.-S.; Pan-Chyr Yang; Huang K.-Y.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:21Z |
Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
|
Shih J.-Y.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Pan-Chyr Yang; Shih J.-Y.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:21Z |
Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome
|
MacHiela M.J.; PAN-CHYR YANG et al.; Machiela M.J.; Zhou W.; Karlins E.; Sampson J.N.; Freedman N.D.; Yang Q.; Hicks B.; Dagnall C.; Hautman C.; Jacobs K.B.; Abnet C.C.; Aldrich M.C.; Amos C.; Amundadottir L.T.; Arslan A.A.; Beane-Freeman L.E.; Berndt S.I.; Black A.; Blot W.J.; Bock C.H.; Bracci P.M.; Brinton L.A.; Bueno-De-Mesquita H.B.; Burdett L.; Buring J.E.; Butler M.A.; Canzian F.; Carre?N T.; Chaffee K.G.; Chang I.-S.; Chatterjee N.; Chen C.; Chen C.; Chen K.; Chung C.C.; Cook L.S.; Crous Bou M.; Cullen M.; Davis F.G.; De Vivo I.; Ding T.; Doherty J.; Duell E.J.; Epstein C.G.; Fan J.-H.; Figueroa J.D.; Fraumeni J.F.; Friedenreich C.M.; Fuchs C.S.; Gallinger S.; Gao Y.-T.; Gapstur S.M.; Garcia-Closas M.; Gaudet M.M.; Gaziano J.M.; Giles G.G.; Gillanders E.M.; Giovannucci E.L.; Goldin L.; Goldstein A.M.; Haiman C.A.; Hallmans G.; Hankinson S.E.; Harris C.C.; Henriksson R.; Holly E.A.; Hong Y.-C.; Hoover R.N.; Hsiung C.A.; Hu N.; Hu W.; Hunter D.J.; Hutchinson A.; Jenab M.; Johansen C.; Khaw K.-T.; Kim H.N.; Kim Y.H.; Kim Y.T.; Klein A.P.; Klein R.; Koh W.-P.; Kolonel L.N.; Kooperberg C.; Kraft P.; Krogh V.; Kurtz R.C.; Lacroix A.; Lan Q.; Landi M.T.; Marchand L.L.; Li D.; Liang X.; Liao L.M.; Lin D.; Liu J.; Lissowska J.; Lu L.; Magliocco A.M.; Malats N.; Matsuo K.; Mcneill L.H.; Mcwilliams R.R.; Melin B.S.; Mirabello L.; Moore L.; Olson S.H.; Orlow I.; Park J.Y.; Patin?-Garcia A.; Peplonska B.; Peters U.; Petersen G.M.; Pooler L.; Prescott J.; Prokunina-Olsson L.; Purdue M.P.; Qiao Y.-L.; Rajaraman P.; Real F.X.; Riboli E.; Risch H.A.; Rodriguez-Santiago B.; Ruder A.M.; Savage S.A.; Schumacher F.; Schwartz A.G.; Schwartz K.L.; Seow A.; Wendy Setiawan V.; Severi G.; Shen H.; Sheng X.; Shin M.-H.; Shu X.-O.; Silverman D.T.; Spitz M.R.; Stevens V.L.; Stolzenberg-Solomon R.; Stram D.; Tang Z.-Z.; Taylor P.R.; Teras L.R.; Tobias G.S.; Van Den Berg D.; Visvanathan K.; Wacholder S.; Wang J.-C.; Wang Z.; Wentzensen N.; Wheeler W.; White E.; Wiencke J.K.; Wolpin B.M.; Wong M.P.; Wu C.; Wu T.; Wu X.; Wu Y.-L.; Wunder J.S.; Xia L.; Yang H.P.; Pan-Chyr Yang; Yu K.; Zanetti K.A.; Zeleniuch-Jacquotte A.; Zheng W.; Zhou B.; Ziegler R.G.; Perez-Jurado L.A.; Caporaso N.E.; Rothman N.; Tucker M.; Dean M.C.; Yeager M.; Chanock S.J. |
| 臺大學術典藏 |
2020-12-02T02:33:20Z |
The Prognostic Significance of pSTAT1 and CD163 Expressions in Surgically Resected Stage 1 Pulmonary Squamous Cell Carcinomas
|
Lin M.-W.; Yang C.-Y.; Kuo S.-W.; Wu C.-T.; Chang Y.-L.; Pan-Chyr Yang; Lin M.-W.; Yang C.-Y.; Kuo S.-W.; Wu C.-T.; Chang Y.-L.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:20Z |
Does a rifamycin-containing preventive regimen increase rifampicin resistance? An unresolved concern
|
Wang J.-Y.; Pan-Chyr Yang; Wang J.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:20Z |
Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients
|
Hsu K.-H.; Tseng J.-S.; Wang C.-L.; Yang T.-Y.; Tseng C.-H.; Chen H.-Y.; Chen K.-C.; Tsai C.-R.; Yang C.-T.; Yu S.-L.; Su K.-Y.; Yu C.-J.; Ho C.C.; Hsia T.-C.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Pan-Chyr Yang; Chen J.J.W.; Chang G.-C.; Hsu K.-H.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:19Z |
Kinesin-5 Contributes to Spindle-length Scaling in the Evolution of Cancer toward Metastasis
|
PAN-CHYR YANG; Huang H.-C.; Lai P.-L.; Liang K.-W.; Pan C.-J.; Tsai W.-Y.; Chen W.-A.; Yang C.-F.; Yang C.-F.; Tsai W.-Y.; Chen W.-A.; Liang K.-W.; Pan C.-J.; Lai P.-L.; Pan-Chyr Yang; Huang H.-C. |
| 臺大學術典藏 |
2020-12-02T02:33:19Z |
The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition
|
Wu S.-G.; Chang Y.-L.; Yu C.-J.; Pan-Chyr Yang; Shih J.-Y.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; PAN-CHYR YANG; Shih J.-Y. |
| 臺大學術典藏 |
2020-12-02T02:33:19Z |
Purine-Type Compounds Induce Microtubule Fragmentation and Lung Cancer Cell Death through Interaction with Katanin
|
Kuo T.-C.; Li L.-W.; Pan S.-H.; Fang J.-M.; Liu J.-H.; Cheng T.-J.; Wang C.-J.; Hung P.-F.; Chen H.-Y.; Hong T.-M.; Hsu Y.-L.; Wong C.-H.; Pan-Chyr Yang; Kuo T.-C.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:19Z |
Randomized phase II trial of gefitinib with and without pemetrexed as first-line therapy in patients with advanced nonsquamous non-small-cell lung cancer with activating epidermal growth factor receptor mutations
|
Cheng Y.; Murakami H.; Pan-Chyr Yang; He J.; Nakagawa K.; Kang J.H.; Kim J.-H.; Wang X.; Enatsu S.; Puri T.; Orlando M.; Yang J.C.-H.; Cheng Y.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:18Z |
The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients
|
Thongprasert S.; Pan-Chyr Yang; Lee J.S.; Soo R.; Gruselle O.; Myo A.; Louahed J.; Lehmann F.F.; Brichard V.G.; Coche T.; Thongprasert S.; PAN-CHYR YANG; Lee J.S.; Soo R.; Gruselle O.; Myo A.; Louahed J.; Lehmann F.F.; Brichard V.G.; Coche T. |
| 臺大學術典藏 |
2020-12-02T02:33:18Z |
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms
|
Chen C.-H.; Chang W.-H.; Su K.-Y.; Ku W.-H.; Chang G.-C.; Hong Q.-S.; Hsiao Y.-J.; Chen H.-C.; Chen H.-Y.; Wu R.; Pan-Chyr Yang; Chen J.J.W.; Yu S.-L.; Chen C.-H.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:17Z |
Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis
|
Lin C.-W.; Wang L.-K.; Wang S.-P.; Chang Y.-L.; Wu Y.-Y.; Chen H.-Y.; Hsiao T.-H.; Lai W.-Y.; Lu H.-H.; Chang Y.-H.; Yang S.-C.; Lin M.-W.; Chen C.-Y.; Hong T.-M.; Pan-Chyr Yang; Lin C.-W.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:17Z |
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis
|
Ruiz-Palacios G.M.; Leroux-Roels G.; Beran J.; Devaster J.-M.; Esen M.; Launay O.; Mcelhaney J.E.; Van Essen G.A.; Benoit A.; Claeys C.; Dew? W.; Durand C.; Duval X.; Falsey A.R.; Feldman G.; Galtier F.; Gervais P.; Hwang S.-J.; Mcneil S.; Richardus J.H.; Trofa A.; Oostvogels L.; For The Influence65 Study Group, Arnould P.-H.; Balthazar Y.; Batens A.H.; Coppens H.; Demeulemeester M.; Dewitte P.; Devriendt L.; Leroux-Roels G.; Mathot G.; Maury O.; Muylaert P.; Renson A.; Soetaert P.; Tilley L.; Van Riet D.; Vanden Bemden S.; Aggarwal N.; Blouin F.; Ferguson M.; Lasko B.; Mcelhaney J.; Mcneil S.; Powell C.; Rheault P.; Shu D.; St-Amour E.; Beran J.; Chocensky V.; Koort I.; Maasalu K.; Poder A.; Randvee L.; Rosenthal S.; Stern M.; Talli J.; Arnou R.; Bortolotti C.; Duval X.; Ferrier R.; Fivel C.; Foucault J.-F.; Galtier F.; Igigabel P.; Launay O.; Saillard D.; Scellier C.; Tondut J.; Uge P.; Beck E.; Burkhardt F.; Colberg A.; Dahmen A.; Deckelmann R.; Dietrich H.; Dominicus R.; Drescher T.; Eckermann T.; Elefant U.; Esen M.; Fahron G.; Fischer S.; Foerster K.; Folesky H.; Gehling U.; Grigat C.; Himpel-Boenninghoff A.; Hoeschele P.; H?Ltz S.; Huber B.; Ilg S.; Illies G.; Jansen J.-P.; Kaessner F.; Kieninger D.; Klein C.; Kleinecke-Pohl U.; Kluge A.; Kratschmann W.; Krause K.H.; Kremsner P.; Kropp J.; Langenbrink A.; Lehmann R.; Linnhoff A.; Markendorf A.; Meissner G.; Meyer I.; Moeckesch B.; Mueller M.; Mueller S.; Neumann G.; Paschen C.; Plassmann G.; Ponitz H.-H.; Preusche A.; Rinke A.; Samer H.; Schaberg T.; Schaper F.; Schenkenberger I.; Schmidt J.; Schmitt B.; Schneider H.; Schumacher M.; Schwarz T.; Stahl H.-D.; Steinbach K.; Steinhauser U.; Stockhausen J.; Stolz B.; Toursarkissian N.; Tyler K.; Wachter J.; Weber H.G.; Weyland K.; Wolf D.; Zitzmann K.; Aranza Doniz C.; Guerrero M.L.; Lazcano- Ponce E.; Mascare?As De Los Santos A.; Pavia-Ruz N.; Ruiz- Palacios G.M.; Van Essen G.A.; Richardus J.H.; Rumke H.; Elle S.; Holmberg A.; H?Ivik H.O.; Kj?Rnli T.; Norheim P.; Tandberg A.; Gadzinski W.; Holda J.; Jazwinska- Tarnawska E.; Lepich T.; Lysek R.; Nowakowska H.; Orzechowska M.; Szumlanska Z.; Abaitancei A.; Orban S.; Vasilache F.; Toma D.; Osipova I.; Perminova O.; Semerikov V.; Hwang S.-J.; Pan-Chyr Yang; Abdulhakim E.; Pavel-Knox I.; Shaw H.; Blatter M.; Boos D.; Bowling B.; Bowman S.; Brune D.; Christensen S.; Christensen T.; Civitarese L.; El Sahly H.; Earl J.; Ervin J.; Essink B.; Falsey A.R.; Feldman G.; Fiel T.; Fogarty C.; Folkerth S.; Frey S.E.; Fried D.; Gibson G.; Hall M.; Harper W.; Hull S.; Jacobson J.; Jacqmein J.; Lawless J.; Lucasti C.; Poling T.; Raad G.; Ramsbottom G.; Reisinger K.; Riffer E.; Rosen J.; Ross E.; Rubino J.; Sperber S.; Studdard H.; Thrasher J.; Turner M.; Van Cleeff M.; Wadsworth L.; Yakish J.; Ruiz-Palacios G.M.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:16Z |
Turning diversity toward precision
|
Lin P.-Y.;Chen H.-Y.;Yu S.-L.;Pan-Chyr Yang; Lin P.-Y.; Chen H.-Y.; Yu S.-L.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:16Z |
High PD-L1 expression is associated with stage IV disease and poorer overall survival in 186 cases of small cell lung cancers
|
Chang Y.-L.;Yang C.-Y.;Huang Y.-L.;Wu C.-T.;Pan-Chyr Yang; Chang Y.-L.; Yang C.-Y.; Huang Y.-L.; Wu C.-T.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:16Z |
Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations
|
Seow W.J.; Matsuo K.; Hsiung C.A.; Shiraishi K.; Song M.; Namkim H.; Wong M.P.; Hong Y.-C.; Dean Hosgood H.; Iii, Wang Z.; Chang I.-S.; Wang J.-C.; Chatterjee N.; Tucker M.; Wei H.; Mitsudomi T.; Zheng W.; Kim J.H.; Zhou B.; Caporaso N.E.; Albanes D.; Shin M.-H.; Chung L.P.; An S.-J.; Wang P.; Zheng H.; Yatabe Y.; Zhang X.-C.; Kim Y.T.; Shu X.-O.; Kim Y.-C.; Bassig B.A.; Chang J.; Man Ho J.C.; Ji B.-T.; Kubo M.; Daigo Y.; Ito H.; Momozawa Y.; Ashikawa K.; Kamatani Y.; Honda T.; Sakamoto H.; Kunitoh H.; Tsuta K.; Watanabe S.-I.; Nokihara H.; Miyagi Y.; Nakayama H.; Matsumoto S.; Tsuboi M.; Goto K.; Yin Z.; Shi J.; Takahashi A.; Goto A.; Minamiya Y.; Shimizu K.; Tanaka K.; Wu T.; Wei F.; Wong J.Y.Y.; Matsuda F.; Su J.; Kim Y.H.; Oh I.-J.; Song F.; Lee V.H.F.; Su W.-C.; Chen Y.-M.; Chang G.-C.; Chen K.-Y.; Huang M.-S.; Pan-Chyr Yang; Lin H.-C.; Xiang Y.-B.; Seow A.; Park J.Y.; Kweon S.-S.; Chen C.-J.; Li H.; Gao Y.-T.; Wu C.; Qian B.; Lu D.; Liu J.; Jeon H.-S.; Hsiao C.-F.; Sung J.S.; Tsai Y.-H.; Jung Y.J.; Guo H.; Hu Z.; Wang W.-C.; Chung C.C.; Lawrence C.; Burdett L.; Yeager M.; Jacobs K.B.; Hutchinson A.; Berndt S.I.; He X.; Wu W.; Wang J.; Li Y.; Choi J.E.; Park K.H.; Sung S.W.; Liu L.; Kang C.H.; Hu L.; Chen C.-H.; Yang T.-Y.; Xu J.; Guan P.; Tan W.; Wang C.-L.; Loon Sihoe A.D.; Chen Y.; Choi Y.Y.; Hung J.-Y.; Kim J.S.; Yoon H.-I.; Cai Q.; Lin C.-C.; Park I.K.; Xu P.; Dong J.; Kim C.; He Q.; Perng R.-P.; Chen C.-Y.; Vermeulen R.; Wu J.; Lim W.-Y.; Chen K.-C.; Chan J.K.; Chu M.; Li Y.-J.; Li J.; Chen H.; Yu C.-J.; Jin L.; Lo Y.-L.; Chen Y.-H.; Fraumeni J.F.; Jr, Liu J.; Yamaji T.; Yang Y.; Hicks B.; Wyatt K.; Li S.A.; Dai J.; Ma H.; Jin G.; Song B.; Wang Z.; Cheng S.; Li X.; Ren Y.; Cui P.; Iwasaki M.; Shimazu T.; Tsugane S.; Zhu J.; Jiang G.; Fei K.; Wu G.; Chien L.-H.; Chen H.-L.; Su Y.-C.; Tsai F.-Y.; Chen Y.-S.; Yu J.; Stevens V.L.; Laird-Offringa I.A.; Marconett C.N.; Lin D.; Chen K.; Wu Y.-L.; Landi M.T.; Shen H.; Rothman N.; Kohno T.; Chanock S.J.; Lan Q.; Seow W.J.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:15Z |
Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer
|
Wang Y.-T.; Pan S.-H.; Tsai C.-F.; Kuo T.-C.; Hsu Y.-L.; Yen H.-Y.; Choong W.-K.; Wu H.-Y.; Liao Y.-C.; Hong T.-M.; Sung T.-Y.; Pan-Chyr Yang; Chen Y.-J.; Wang Y.-T.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:15Z |
Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors
|
Chang I.-S.; Jiang S.S.; Yang J.C.-H.; Su W.-C.; Chien L.-H.; Hsiao C.-F.; Lee J.-H.; Chen C.-Y.; Chen C.-H.; Chang G.-C.; Wang Z.; Lo F.-Y.; Chen K.-Y.; Wang W.-C.; Chen Y.-M.; Huang M.-S.; Tsai Y.-H.; Su Y.-C.; Hsieh W.-S.; Shih W.-C.; Shieh S.-H.; Yang T.-Y.; Lan Q.; Rothman N.; Chen C.-J.; Chanock S.J.; Pan-Chyr Yang; Hsiung C.A.; Chang I.-S.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:15Z |
Corrigendum: Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis
|
Lin C.-W.; Wang L.-K.; Wang S.-P.; Chang Y.-L.; Wu Y.-Y.; Chen H.-Y.; Hsiao T.-H.; Lai W.-Y.; Lu H.-H.; Chang Y.-H.; Yang S.-C.; Lin M.-W.; Chen C.-Y.; Hong T.-M.; Pan-Chyr Yang; Lin C.-W.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:14Z |
A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect
|
PAN-CHYR YANG; Lin E.P.-Y.; Yeh S.-D.; Wang J.-W.; Chang Y.-C.; Lai W.-Y.; Huang B.-T.;Lai W.-Y.;Chang Y.-C.;Wang J.-W.;Yeh S.-D.;Lin E.P.-Y.;Pan-Chyr Yang; Huang B.-T. |
